ArticleRSC advances2026
Modified Amberlyst 15 for continuous glycerol-free biodiesel production from rice bran oil fatty acid distillate.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study developed a modified Amberlyst 15 (A15) catalyst for the production of glycerol-free biodiesel from rice bran oil fatty acid distillate (RBOFAD), a low-quality feedstock with high free fatty acid content. A15 was selected as the catalyst platform because of its strong Brønsted acidity and good stability; however, its direct application is limited by textural constraints and restricted access to acid sites. To overcome these limitations, A15 was modified through thermal treatment followed by acid-site regeneration to enhance both pore accessibility and catalytic functionality. The optimized modified catalyst exhibited a 140.5% increase in surface area and an 11.6% increase in acid density compared with the as-received A15. The catalyst was then applied to the continuous production of biodiesel, using dimethyl carbonate as a glycerol-free acyl acceptor. The effects of key operating variables were systematically investigated and optimized using a design-of-experiments approach. Under optimal conditions of 120 °C, a residence time of 60 min, and a DMC-to-RBOFAD weight ratio of 3 : 1, the modified catalyst achieved a % FAME of 87.5%. In addition, the catalyst showed good preliminary operational stability over 30 h of time-on-stream. The influence of Zn loading on the modified A15 catalyst was also evaluated, but it did not further improve its catalytic performance. Benchmarking against related catalyst-based biodiesel production systems showed that the modified A15 catalyst provided competitive performance under substantially milder operating conditions. These findings demonstrate that catalyst modification combined with acid-site regeneration is a practical and effective strategy for improving continuous glycerol-free biodiesel production from low-quality, high-FFA feedstocks.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.